Study Details

HMO Treatment of Depression Co-morbid with Substance Abuse—SODAS

Gregory N. Clarke, Principal Investigator
Donald K. Freeborn,Frances L. Lynch, Bentson H. McFarland, John P. Mullooly, Michael R. Polen, Co-Investigators

 This randomized, controlled trial tested whether concurrent treatment for depression and alcohol and other drug (AOD) disorders improves drinking outcomes (percent days abstinent from alcohol and mean standard drinks per possible drinking day) and depression. Consenting adults entering the intensive outpatient treatment program in the Kaiser Permanente Northwest Addictions Medicine department were screened for depression and alcohol problems. Qualifying participants were assigned to usual care or usual care plus 8 individual sessions of cognitive-behavioral treatment for depression. We followed up with participants at 3, 6, 9, and 12 months after treatment started.
Funding source: National Institute on Alcohol Abuse and Alcoholism

Our Locations
Three Regions — One Mission
Each CHR site conducts professionally independent, public domain research and disseminates its findings in the scholarly literature and scientific community.

Northwest
 3800 N. Interstate
Portland, OR 97227      
503.335.2400

Hawaii
 711 Kapiolani Blvd.
Suite 200
Honolulu, HI 96813
101.222.2400 		Southeast
 3495 Piedmont Road, NE
Ten Piedmont Center,
Suite 205
Atlanta, GA 30305
202.555.1212

US Map

 
Kaiser Permanente